Archive for 'Tag Archives: 'Clinical Trials''
Cardio3 BioSciences’ publishes Phase II trial results for stem cell therapy treatment in the JACC and increases its equity by €19 million.
Two exciting new announcements have recently been made by Belgian-based biotechnology company Cardio3 BioSciences(Mont-Saint Guibert, Wallonia). In early April the company announced the publication of Phase II trial results for stem cell therapy C-Cure® in the [...]
CluePoints holds official inauguration* of new office in Mont Saint Guibert and launches solution for risk-based monitoring using the SMART™ engine approach
IDDI (International Drug Development Institute) has recently launched its subsidiary entitled CluePoints, the new software and service provider of Intelligent Statistical Monitoring Solutions. This exciting new development is a follow-up to the IDDI article published last [...]
DNAVision(Gosselies, Belgium) among the first in Europe to receive the ISO 17025 accreditation of exome sequencing service for clinical applications.
An external audit carried out by the Belgian Authorities recently validated DNAVision’s (Gosselies, Belgium) technical competence to carry out exome sequencing* and the ability to consistently produce valid and traceable results. This important validation will allow [...]
Bone Therapeutics gets approval for pivotal phase III osteonecrosis trial in Europe and treats first patients with their Advanced Therapy Medicinal Product PREOB®
After receiving clearance from the competent authorities in Europe for its phase III pivotal osteonecrosis* trial with their second generation Advanced Therapy Medicinal Product (ATMP), PREOB®, bone regenerative medicine company Bone Therapeutics recently announced that their [...]